MERCK KGAA's Capital Markets Day sparked a 7.6% market rise, despite dampened pharmaceutical expectations following setbacks in drug development. The Electronics division, particularly Semiconductor Materials, is projected to grow sales by 5-9% annually, while pharmaceuticals anticipate slight growth through licensing. Analysts remain optimistic, with target prices from DEUTSCHE BANK at €180 and GOLDMAN SACHS at €205, reflecting a calming effect from the event.
Belen Garijo, leading Merck KGaA, is focusing on oncology and immunology despite a 30% drop in stock since its 2021 peak. The company, with roots dating back to the 17th century, has three business units and is enhancing investments in China while bolstering local supply chains.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
